The splicing factor SR2 is an important virulence factor of Toxoplasma gondii

Serine/arginine-rich (SR) proteins are key factors with important roles in constitutive and alternative splicing (AS) of pre-mRNAs. However, the role of SR splicing factors in the pathogenicity of T. gondii remains largely unexplored. Here, we investigated the role of splicing factor SR2, a homolog...

Full description

Bibliographic Details
Main Authors: Xiao-Jing Wu, Jin Gao, Xiao-Nan Zheng, Hany M. Elsheikha, Ting-Ting Li, Yong-Jie Kou, Meng Wang, Xing-Quan Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1302512/full
_version_ 1797500956857860096
author Xiao-Jing Wu
Xiao-Jing Wu
Jin Gao
Jin Gao
Xiao-Nan Zheng
Hany M. Elsheikha
Ting-Ting Li
Yong-Jie Kou
Yong-Jie Kou
Meng Wang
Xing-Quan Zhu
author_facet Xiao-Jing Wu
Xiao-Jing Wu
Jin Gao
Jin Gao
Xiao-Nan Zheng
Hany M. Elsheikha
Ting-Ting Li
Yong-Jie Kou
Yong-Jie Kou
Meng Wang
Xing-Quan Zhu
author_sort Xiao-Jing Wu
collection DOAJ
description Serine/arginine-rich (SR) proteins are key factors with important roles in constitutive and alternative splicing (AS) of pre-mRNAs. However, the role of SR splicing factors in the pathogenicity of T. gondii remains largely unexplored. Here, we investigated the role of splicing factor SR2, a homolog of Plasmodium falciparum SR1, in the pathogenicity of T. gondii. We functionally characterized the predicted SR2 in T. gondii by gene knockout and studied its subcellular localization by endogenous protein HA tagging using CRISPR-Cas9 gene editing. The results showed that SR2 was localized in the nucleus and expressed in the tachyzoite and bradyzoite stages. In vitro studies including plaque formation, invasion, intracellular replication, egress and bradyzoite differentiation assays showed that deletion of SR2 in type I RH strain and type II Pru strains had no significant effect on the parasite growth and bradyzoite differentiation (p > 0.05). Interestingly, the disruption of SR2 in RH type I (p < 0.0001) and Pru type II (p < 0.05) strains resulted in varying degrees of attenuated virulence. In addition, disruption of SR2 in type II Pru strain significantly reduced brain cyst burden by ~80% (p < 0.0001). Collectively, these results suggest that splicing factor SR2 is important for the pathogenicity of T. gondii, providing a new target for the control and treatment of toxoplasmosis.
first_indexed 2024-03-10T03:11:20Z
format Article
id doaj.art-290a34a47dc34747be56424b19479b7e
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-03-10T03:11:20Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-290a34a47dc34747be56424b19479b7e2023-11-23T10:23:59ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-11-011410.3389/fmicb.2023.13025121302512The splicing factor SR2 is an important virulence factor of Toxoplasma gondiiXiao-Jing Wu0Xiao-Jing Wu1Jin Gao2Jin Gao3Xiao-Nan Zheng4Hany M. Elsheikha5Ting-Ting Li6Yong-Jie Kou7Yong-Jie Kou8Meng Wang9Xing-Quan Zhu10Laboratory of Parasitic Diseases, College of Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi Province, ChinaState Key Laboratory for Animal Disease Control and Prevention, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, ChinaLaboratory of Parasitic Diseases, College of Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi Province, ChinaState Key Laboratory for Animal Disease Control and Prevention, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, ChinaLaboratory of Parasitic Diseases, College of Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi Province, ChinaFaculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Loughborough, United KingdomState Key Laboratory for Animal Disease Control and Prevention, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, ChinaLaboratory of Parasitic Diseases, College of Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi Province, ChinaState Key Laboratory for Animal Disease Control and Prevention, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, ChinaState Key Laboratory for Animal Disease Control and Prevention, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, ChinaLaboratory of Parasitic Diseases, College of Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi Province, ChinaSerine/arginine-rich (SR) proteins are key factors with important roles in constitutive and alternative splicing (AS) of pre-mRNAs. However, the role of SR splicing factors in the pathogenicity of T. gondii remains largely unexplored. Here, we investigated the role of splicing factor SR2, a homolog of Plasmodium falciparum SR1, in the pathogenicity of T. gondii. We functionally characterized the predicted SR2 in T. gondii by gene knockout and studied its subcellular localization by endogenous protein HA tagging using CRISPR-Cas9 gene editing. The results showed that SR2 was localized in the nucleus and expressed in the tachyzoite and bradyzoite stages. In vitro studies including plaque formation, invasion, intracellular replication, egress and bradyzoite differentiation assays showed that deletion of SR2 in type I RH strain and type II Pru strains had no significant effect on the parasite growth and bradyzoite differentiation (p > 0.05). Interestingly, the disruption of SR2 in RH type I (p < 0.0001) and Pru type II (p < 0.05) strains resulted in varying degrees of attenuated virulence. In addition, disruption of SR2 in type II Pru strain significantly reduced brain cyst burden by ~80% (p < 0.0001). Collectively, these results suggest that splicing factor SR2 is important for the pathogenicity of T. gondii, providing a new target for the control and treatment of toxoplasmosis.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1302512/fullToxoplasma gondiiSR proteinssplicing factor SR2alternative splicingpathogenicityCRISPR-Cas9
spellingShingle Xiao-Jing Wu
Xiao-Jing Wu
Jin Gao
Jin Gao
Xiao-Nan Zheng
Hany M. Elsheikha
Ting-Ting Li
Yong-Jie Kou
Yong-Jie Kou
Meng Wang
Xing-Quan Zhu
The splicing factor SR2 is an important virulence factor of Toxoplasma gondii
Frontiers in Microbiology
Toxoplasma gondii
SR proteins
splicing factor SR2
alternative splicing
pathogenicity
CRISPR-Cas9
title The splicing factor SR2 is an important virulence factor of Toxoplasma gondii
title_full The splicing factor SR2 is an important virulence factor of Toxoplasma gondii
title_fullStr The splicing factor SR2 is an important virulence factor of Toxoplasma gondii
title_full_unstemmed The splicing factor SR2 is an important virulence factor of Toxoplasma gondii
title_short The splicing factor SR2 is an important virulence factor of Toxoplasma gondii
title_sort splicing factor sr2 is an important virulence factor of toxoplasma gondii
topic Toxoplasma gondii
SR proteins
splicing factor SR2
alternative splicing
pathogenicity
CRISPR-Cas9
url https://www.frontiersin.org/articles/10.3389/fmicb.2023.1302512/full
work_keys_str_mv AT xiaojingwu thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT xiaojingwu thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT jingao thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT jingao thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT xiaonanzheng thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT hanymelsheikha thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT tingtingli thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT yongjiekou thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT yongjiekou thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT mengwang thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT xingquanzhu thesplicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT xiaojingwu splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT xiaojingwu splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT jingao splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT jingao splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT xiaonanzheng splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT hanymelsheikha splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT tingtingli splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT yongjiekou splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT yongjiekou splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT mengwang splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii
AT xingquanzhu splicingfactorsr2isanimportantvirulencefactoroftoxoplasmagondii